About Colistogard 2MIU Injection
Discover the last chance to secure Colistogard 2MIU Injection, a rare find in the world of polymyxin antibiotics. This affordable, inestimable solution is designed for those facing severe Gram-negative bacterial infections resistant to common therapies. With its soaring efficacy and sensational reputation, Colistogard-marketed by Cipla Ltd. in India-delivers 2 million IU of Colistimethate Sodium per vial. Suitable for adults and children, its administration is intravenous (IV) or intramuscular (IM) after careful reconstitution. Ideal for hospitals and clinics combating multi-drug resistant pathogens.
Application and Usage of Colistogard 2MIU Injection
Colistogard 2MIU Injection is intended for direct application via intravenous (IV) or intramuscular (IM) injection following precise reconstitution with 10 ml of sterile water. The product is a lyophilized powder, packaged in secure vials, ensuring consistent quality and sterility. This usage type is strictly prescription-based, designed for critical care surfaces-such as hospitals and advanced clinics-in managing severe infections from Gram-negative bacteria. Both adults and children benefit from targeted, physician-guided administration protocols.
Certifications, Samples, and Packaging of Colistogard 2MIU Injection
Colistogard 2MIU Injection adheres to allopathic medicine regulatory standards, with proper prescription-only status ensuring trust and credibility. Export markets rely on professional Goods Transport, seamless Packing & Dispatch, and robust packaging details-each box containing one vial, sealed for maximum potency and safety. Samples may be available upon request for verified distributors and partners. The product promises efficient handling from warehouse to destination, preserving its sensational quality during global distribution.
FAQ's of Colistogard 2MIU Injection:
Q: How should Colistogard 2MIU Injection be prepared and administered?
A: Colistogard 2MIU Injection should be reconstituted with 10 ml of sterile water for injection, then administered either intravenously (IV) or intramuscularly (IM) as directed by a physician.
Q: What infections is Colistogard 2MIU Injection recommended for?
A: Colistogard 2MIU is indicated for severe, multi-drug resistant Gram-negative bacterial infections, including pneumonia, sepsis, and complicated urinary tract infections.
Q: When should Colistogard 2MIU Injection not be used?
A: Colistogard 2MIU Injection is contraindicated in patients with hypersensitivity to colistin or polymyxins. Always consult a physician before use.
Q: Where is Colistogard 2MIU Injection manufactured and marketed from?
A: This product is manufactured and marketed by Cipla Ltd., one of India's leading pharmaceutical companies.
Q: What is the process for ordering and exporting Colistogard 2MIU Injection?
A: The minimum order quantity is one box. For export, trusted distributors can request samples, and all orders are handled with secure packing and swift goods transport.
Q: How long can Colistogard 2MIU Injection be stored after reconstitution?
A: Once reconstituted, the injection should be used immediately or within 24 hours if refrigerated (do not freeze).
Q: What are the storage requirements and shelf life for Colistogard 2MIU Injection?
A: Store below 25C, protected from light and do not freeze. The product's shelf life is 36 months from the date of manufacture.